The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

May 22, 2019

Study Completion Date

May 22, 2019

Conditions
Type 1 Diabetes
Interventions
OTHER

Exercise

24 weeks of exercise treatment

DRUG

Spironolactone

24 weeks of spironolactone

Trial Locations (1)

22906

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Virginia

OTHER

NCT03174288 - The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter